The time from implantation of a prosthesis until a specified event of interest is used in survival analyses.
The secondary endpoint was time from ICD implantation until the first appropriate ICD therapy or death (e.g. death without prior appropriate ICD therapy).
Implant age (time elapsed in vivo) was calculated as the time from the date of implantation until the date of a subject's MRI procedure.
Catheters were filled with a heparin/saline solution from the time of implantation until experimentation and were flushed periodically (Heiser 2007).
"Time to infection" was defined as time from implantation of the prosthesis to clinical onset of infection and was categorized into early (≤3 months after implantation), delayed (>3 to <24 months after implantation), or late (≥24 months after implantation) infection.
It is notable that non-uniform ion dose distribution is obtained at any time during the whole implantation process from the beginning of the implantation until all ions exhausted.
Treatment was for 3 days starting from the day of bead implantation until 1 day before termination.
Mice received intraperitoneal injections of DHMEQ (5 mg kg−1) or DMSO (control group) diluted in RPMI-1640 mevery every day from day 10 after tumour implantation until 2 days before being killed (day 31).
Federal law defines pregnancy from implantation, not fertilisation.
Research recordings were initiated several days post-implantation, after subjects had fully recovered from implantation surgery.
The closest data for comparison is from our previous paper on miRNA expression from implantation and inter-implantation sites in mouse uterus [8].
